Who is sponsoring NCT02783690?

NCT02783690 is sponsored by Mayo Clinic.

What condition does NCT02783690 study?

NCT02783690 studies Breast Cancer.

What drugs are being tested in NCT02783690?

Interventions: Hypofractionation.

What is the status of NCT02783690?

NCT02783690 is currently COMPLETED.

Last reviewed 2025-12-04 · How we verify

A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal Irradiation

NCT02783690 PHASE2 COMPLETED Results posted

This is a randomized controlled trial to determine the safety of 15 fraction vs 25 fraction pencil beam scanning proton radiotherapy after mastectomy in patients requiring regional nodal irradiation. Proton therapy is recognized as a standard option for the delivery of radiotherapy for breast cancer.

Details

Lead sponsor	Mayo Clinic
Phase	PHASE2
Status	COMPLETED
Enrolment	88
Start date	Wed May 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Nov 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Breast Cancer

Interventions

Hypofractionation

Countries

United States